Research Summary
Celecoxib is a medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is commonly prescribed for the management of pain, inflammation, and swelling associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Celecoxib works by inhibiting the production of specific chemicals called prostaglandins, which are responsible for inflammation and pain. Unlike traditional NSAIDs, celecoxib selectively targets the COX-2 enzyme, reducing the risk of stomach ulcers and gastrointestinal side effects. It is available in oral capsule form and is typically taken once or twice a day. However, like all medications, celecoxib may carry certain risks and side effects, so it is essential to use it under the guidance of a healthcare professional and follow the prescribed dosage and duration of treatment.
According to DIResearch's in-depth investigation and research, the global Celecoxib market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Celecoxib include Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Celecoxib. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Celecoxib market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Celecoxib market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Celecoxib industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Celecoxib Include:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Celecoxib Product Segment Include:
50mg
100mg
200mg
400mg
Celecoxib Product Application Include:
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Celecoxib Industry PESTEL Analysis
Chapter 3: Global Celecoxib Industry Porter's Five Forces Analysis
Chapter 4: Global Celecoxib Major Regional Market Size and Forecast Analysis
Chapter 5: Global Celecoxib Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Celecoxib Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Celecoxib Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Celecoxib Market Overview 1.1 Product Definition and Statistical Scope 1.2 Celecoxib Product by Type 1.2.1 Global Celecoxib Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 50mg 1.2.3 100mg 1.2.4 200mg 1.2.5 400mg 1.3 Celecoxib Product by Application 1.3.1 Global Celecoxib Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Rheumatoid arthritis 1.3.3 osteoarthritis 1.3.4 Acute pain 1.3.5 Musculoskeletal pain 1.3.6 Other 1.4 Global Celecoxib Market Revenue Analysis (2019-2030) 1.5 Celecoxib Market Development Status and Trends 1.5.1 Celecoxib Industry Development Status Analysis 1.5.2 Celecoxib Industry Development Trends Analysis 2 Celecoxib Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Celecoxib Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Celecoxib Market Analysis by Regions 4.1 Celecoxib Overall Market: 2023 VS 2024 VS 2030 4.2 Global Celecoxib Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Celecoxib Revenue and Market Share by Region (2019-2024) 4.2.2 Global Celecoxib Revenue Forecast by Region (2025-2030) 5 Global Celecoxib Market Size by Type and Application 5.1 Global Celecoxib Market Size by Type 5.2 Global Celecoxib Market Size by Application 6 North America 6.1 North America Celecoxib Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Celecoxib Market Size by Type 6.4 North America Celecoxib Market Size by Application 6.5 North America Celecoxib Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Celecoxib Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Celecoxib Market Size by Type 7.4 Europe Celecoxib Market Size by Application 7.5 Europe Celecoxib Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Celecoxib Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Celecoxib Market Size by Type 8.4 China Celecoxib Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Celecoxib Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Celecoxib Market Size by Type 9.4 APAC (excl. China) Celecoxib Market Size by Application 9.5 APAC (excl. China) Celecoxib Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Celecoxib Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Celecoxib Market Size by Type 10.4 Latin America Celecoxib Market Size by Application 10.5 Latin America Celecoxib Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Celecoxib Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Celecoxib Market Size by Type 11.4 Middle East & Africa Celecoxib Market Size by Application 11.5 Middle East & Africa Celecoxib Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Celecoxib Market Revenue by Key Manufacturers (2020-2024) 12.2 Celecoxib Competitive Landscape Analysis and Market Dynamic 12.2.1 Celecoxib Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Pfizer Inc 13.1.1 Pfizer Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Pfizer Inc Celecoxib Product Portfolio 13.1.3 Pfizer Inc Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Teva 13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Teva Celecoxib Product Portfolio 13.2.3 Teva Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Mylan 13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Mylan Celecoxib Product Portfolio 13.3.3 Mylan Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Apotex 13.4.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Apotex Celecoxib Product Portfolio 13.4.3 Apotex Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Lupin 13.5.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Lupin Celecoxib Product Portfolio 13.5.3 Lupin Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Hengrui Medicine 13.6.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Hengrui Medicine Celecoxib Product Portfolio 13.6.3 Hengrui Medicine Celecoxib Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Celecoxib Industry Chain Analysis 14.2 Celecoxib Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Celecoxib Typical Downstream Customers 14.4 Celecoxib Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support